Research and Standards of Care
Memorial Sloan Kettering Academic Alliance
The partnership with Memorial Sloan Kettering has resulted
in timely practice adoptions of the latest standards of care to
promote clinical standardization, physician participation in a
disease management team and tumor board conferences as
well as increased patient access to clinical trial activities in the
n In collaboration with disease management and value-based
care teams, the Institute’s number of standards of care metrics
increased by 26 percent from FY18 while maintaining a
compliance rate of 96 percent.
n Completed the review and development of FY19 resources and
capabilities alignment plans with high alignment.
n Miami Cancer Institute’s very own Dr. Leonard Kalman co-authored
a research article for the Official Journal of the
National Comprehensive Cancer Network (JNCCN). The article,
“Engaging Community-Based Cancer Physicians: Experience of
the Memorial Sloan Kettering Cancer Center Cancer Alliance,”
features an analysis of the surveyed value of the Cancer Alliance
to physicians within the Alliance member health systems.
The article reviews the benefits of the partnership such as
physician engagement (tumor boards, lectures, etc.), standards
of care (SOCs) and clinical standardization, cross-learning within
the Alliance community, and collaboration on research and
Disease Management Teams
n Disease management teams participated in monthly operational
meetings, sustained Memorial Sloan Kettering and Miami
Cancer Institute standards of care, initiated or continued
educational symposiums, continued journal club discussions,
reviewed chemotherapy regimens and engaged in multiple
community outreach events. These groups involved a
multispecialty medical and clinical team along with operational
leaders and ancillary staff in order to accomplish the goals set
by disease site.
n Supported 10 disease management team meetings per month
in CY19, managed 95 team meetings. As of June 2019,
launched skin disease management team meeting with medical,
clinical, ancillary staff and operational leaders to support the
multidisciplinary skin cancer program.
n Correlated selective disease site clinical pathways with National
Comprehensive Cancer Network guidelines to develop drafts for
n Collaborated with cancer committee to set plans and goals
and monitor standards compliance for the American College
of Surgeons Commission on Cancer accreditation for the
integrated network cancer program including Miami Cancer
Institute, Baptist and South Miami Hospitals.